Breaking News Instant updates and real-time market news.

ADP

ADP

$111.22

1.08 (0.98%)

, OLN

Olin

$35.96

-0.73 (-1.99%)

04:55
11/29/17
11/29
04:55
11/29/17
04:55

Citigroup to hold a conference

Equities, Basic Materials Conference is being held in New York on November 28-29.

ADP

ADP

$111.22

1.08 (0.98%)

OLN

Olin

$35.96

-0.73 (-1.99%)

LYB

LyondellBasell

$104.94

0.56 (0.54%)

HUN

Huntsman

$32.29

1.51 (4.91%)

GRA

W.R. Grace

$74.55

0.58 (0.78%)

KRA

Kraton

$48.90

0.28 (0.58%)

PPG

PPG

$117.34

1.49 (1.29%)

TROX

Tronox

$25.98

-1.44 (-5.25%)

  • 05

    Dec

  • 02

    Mar

ADP ADP
$111.22

1.08 (0.98%)

08/17/17
SBSH
08/17/17
NO CHANGE
Target $110
SBSH
Neutral
ADP placed on positive Catalyst Watch list at Citi
Citi analyst Ashwin Shirvaikar placed on ADP on its 90-day positive Catalyst Watch list while raising his price target for the shares to $110 from $98. The analyst keeps a Neutral rating on the name. Regardless of the outcome with Pershing Square, ADP will "tighten up its planning, delivery and operations in order to show it offers a better/safer alternative," Shirvaikar tells investors in a research note. He believes this should lead to a higher "base case" outcome for ADP, or $110 per share.
11/14/17
MSCO
11/14/17
UPGRADE
Target $114
MSCO
Equal Weight
ADP resumed at Equal Weight, up from Underweight, at Morgan Stanley
Morgan Stanley analyst Danyal Hussain resumed coverage of ADP with an Equal Weight rating and $114 price target, up from the Underweight rating and $100 price target the firm had before it went to restricted on the stock. Following its recent proxy victory, Hussain expects ADP to execute with a greater sense of urgency, but there is still "more work to do" and the proxy fight has put a spotlight on some concerns on which investors will remain focused, including margins and potential share losses, he tells investors.
11/14/17
11/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coca-Cola (KO) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the shares should be a core holding in 2018 and beyond. 2. Deutsche Bank (DB) upgraded to Buy from Hold at HSBC with analyst Alevizos Alevizakos saying the current valuation seemingly ignores the upside inherent in the bank's improved capital position. 3. Famous Dave's (DAVE) upgraded to Buy from Hold at Craig-Hallum with analyst Alex Fuhrman citing the third quarter results beat, refranchising efforts progressing well and further G&A reductions targeted. 4. ADP (ADP) resumed at Equal Weight, up from Underweight, at Morgan Stanley with analyst Danyal Hussain saying he expects ADP to execute with a greater sense of urgency, but there is still "more work to do" and the proxy fight has put a spotlight on some concerns on which investors will remain focused, including margins and potential share losses, he tells investors. 5. Phoenix New Media (FENG) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/17/17
EVER
08/17/17
NO CHANGE
Target $115
EVER
In Line
ADP will have difficulty reaching Pershing's margin goal, says Evercore ISI
Evercore ISI analyst David Togut believes Pershing Square today made a "strong case" for EBIT margin expansion at ADP. The analyst, however, believes 1,200 basis points of EBIT margin expansion by fiscal year 2022 will be "very difficult to achieve." Togut keeps an In Line rating on ADP with a $115 price target.
OLN Olin
$35.96

-0.73 (-1.99%)

10/10/17
COWN
10/10/17
NO CHANGE
Target $42
COWN
Outperform
Olin price target raised to $42 from $39 at Cowen
Cowen analyst Charles Nievert raised his price target on Olin to $42 from $39 to reflect his updated outlook on chlor-alkali and epoxy production and pricing, which he believes will be more robust than he initially estimated. Nievert reiterated his Outperform rating on Olin shares.
10/02/17
RHCO
10/02/17
NO CHANGE
RHCO
Olin price target raised to $44 from $36 at SunTrust
SunTrust analyst Jason Freuchtel raised his price target on Olin based on a $20 per ton increase in the price of caustic soda which was reportedly accepted by the market. The analyst increased his 2018 EBITDA estimate for the company to $1.29B. He expects the stock to command a higher multiple based on the increased outlook for caustic soda prices, and he keeps a Buy rating on the shares.
09/27/17
SBSH
09/27/17
INITIATION
Target $39
SBSH
Buy
Olin initiated with a Buy at Citi
Citi analyst Eric Petrie started Olin Corp. with a Buy rating and $39 price target. The analyst believes the electrochemical unit upcycle facilitated by industry rationalization and consolidation is in the early innings.
09/27/17
09/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX), JD.com (JD) initiated with an Outperform at Wells Fargo, and Baidu (BIDU) were initiated with an Outperform at Wells Fargo. 2. Zealand Pharma (ZEAL) initiated with a Buy at Goldman Sachs. 3. Olin (OLN) initiated with a Buy at Citi. 4. First Horizon (FHN) resumed with an Equal Weight at Morgan Stanley. 5. CRH (CRH) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
LYB LyondellBasell
$104.94

0.56 (0.54%)

11/07/17
SBSH
11/07/17
NO CHANGE
Target $38
SBSH
Buy
Huntsman may become target for company like LyondellBasell, says Citi
Citi analyst P.J. Juvekar this morning resumed coverage of Huntsman (HUN) with a Buy rating and raised his price target for the shares to $38 from $29. Huntsman has been a willing participant in the consolidation of the chemicals industry and may become a target for a company like LyondellBasell (LYB), Juvekar wrote earlier in a research note. The analyst sees overlap of Polyurethanes and potential synergies of up to $250M from such a combination. Juvekar, in addition, likes Huntsman's focus on improving free cash flow. The stock in morning trading is up 49c to $31.48.
10/31/17
RBCM
10/31/17
NO CHANGE
Target $110
RBCM
Sector Perform
LyondellBasell price target raised to $110 from $102 at RBC Capital
RBC Capital analyst Arun Viswanathan raised his price target on LyondellBasell (LYB) to $110 and kept his Sector Perform rating. Viswanathan says stronger Q4 pricing should offset headwinds related to US Gulf Coast hurricanes and the takeover of Braskem (BAK) could be about 20% accretive. Viswanathan says some caution is warranted until there is a better sense of the magnitude of margin deterioration from oncoming supply.
09/26/17
NOMU
09/26/17
UPGRADE
Target $98
NOMU
Buy
Westlake Chemical upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst Aleksey Yefremov upgraded Westlake Chemical (WLK) to Buy and raised his price target for the shares to $98 from $77. Strong earnings in the Vinyls segment should more than offset declines in Olefins, Yefremov tells investors in a research note. He believes supply disruptions from Hurricane Harvey as well as strong demand and seasonal maintenance in Asia reduce downside risk. The analyst sees an upside case to $118 after his firm made upside revisions to its caustic soda price forecast. He also raised his price target for Neutral-rated LyondellBasell (LYB) to $99 from $90.
10/10/17
HSBC
10/10/17
DOWNGRADE
Target $102
HSBC
Hold
LyondellBasell downgraded to Hold from Buy at HSBC
HSBC analyst Sriharsha Pappu downgraded LyondellBasell Industries to Hold citing valuation with the shares up 17% since the start of Q3. The analyst says he remains cautious on the ethylene chain. He raised his price target for the shares to $102 from $101.
HUN Huntsman
$32.29

1.51 (4.91%)

10/10/17
NOMU
10/10/17
DOWNGRADE
NOMU
Neutral
Eastman Chemical downgraded to Neutral from Buy at Nomura Instinet
Nomura Instinet analyst Aleksey Yefremov downgraded Eastman Chemical (EMN) to Neutral citing valuation with shares nearing his unchanged price target of $91. Into the Q3 earnings reports for Chemicals, Yefremov likes Huntsman (HUN) and Venator Materials (VNTR). The analyst remains cautious on Axalta Coating (AXTA) and Celanese (CE). Yefremov lowered his price target for Axalta to $28 from $30 while raising his price target for Buy-rated Albemarle (ALB) to $154 from $146.
10/31/17
RHCO
10/31/17
NO CHANGE
Target $40
RHCO
Buy
Huntsman price target raised to $40 from $32 at SunTrust
SunTrust analyst James Sheehan raised his price target on Huntsman to $40 and kept his Buy rating following Q3 results. Sheehan says the company's recent historically low valuation reflected low free cash flow generation and high leverage. However, the analyst notes that Huntsman's year-to-date free cash flow puts it on target to reach $450M in FY17 versus its $350M target, while leverage has declined to 2.2-times from 3.7-times year ago thanks to the Venator IPO proceeds.
10/30/17
NOMU
10/30/17
NO CHANGE
Target $40
NOMU
Buy
Huntsman price target raised to $40 from $34 at Nomura Instinet
Nomura Instinet analyst Aleksey Yefremov raised his price target for Huntsman to $40 saying the company remains one of his top picks in chemicals following the Q3 earnings report. Fundamentals of MDI cycle are better that what consensus implies, the analyst contends. He keeps a Buy rating on the shares.
GRA W.R. Grace
$74.55

0.58 (0.78%)

10/26/17
KEYB
10/26/17
NO CHANGE
Target $84
KEYB
Overweight
W.R. Grace price target raised to $84 from $77 at KeyBanc
KeyBanc analyst Michael Sison raised his price target for W.R. Grace to $84 from $77 given the improving results and the opportunity for large M&A in catalysts. The analyst believes the company can be aggressive with its balance sheet in the active M&A environment prevalent in the chemical industry, which could boost earnings growth near and longer term. In addition, demand for its catalysts remains strong and its licensing business has a growing backlog driven by growth in the MTO industry, he contends. Sison reiterates an Overweight rating on the shares.
10/25/17
LOOP
10/25/17
NO CHANGE
Target $81
LOOP
Buy
Chicago Bridge & Iron may be a fit for W.R. Grace M&A, says Loop Capital
Loop Capital analyst Chris Kapsch speculates that W.R. Grace (GRA) is poised to pull the trigger on M&A and sees Chicago Bridge & Iron (CBI) as an "obvious fit" when the latter reports Q3 results early next week. Kapsch says W.R.Grace is the "most likely to succeed" as a suitor in the process and models about 60c of EPS accretion sans equity from the deal. The analyst also maintains his Buy rating and $81 price target on W.R. Grace following Q3 results, as the company overcame a $4M EBIT impact from Hurricane Harvey, adding the 7% increase in Catalyst segment volume comp is "encouraging."
09/28/17
LOOP
09/28/17
INITIATION
LOOP
Buy
W.R. Grace initiated with a Buy at Loop Capital
Loop Capital analyst Chris Kapsch initiated W.R. Grace with a Buy rating and $81 price target.
10/10/17
BARD
10/10/17
NO CHANGE
Target $85
BARD
Outperform
Honeywell portfolio changes could 'reignite' W.R. Grace rumors, says Baird
Baird analyst Ben Kallo said Honeywell's (HON) announcement of plans to spin off its Transportation Systems and Homes and Global Distribution businesses and keeps its other units, including its UOP business, could "reignite" take-out rumors regarding W.R Grace (GRA). Honeywell said it sees investment opportunities in all of its remaining units, including UOP, adding that it will have sufficient capacity to pursue M&A, noted Kallo. He keeps an Outperform rating and $85 price target on W.R. Grace shares, but said that an acquisition is not central to his positive view on the stock.
KRA Kraton
$48.90

0.28 (0.58%)

10/11/17
RHCO
10/11/17
NO CHANGE
Target $55
RHCO
Buy
Kraton price target raised to $55 from $45 at SunTrust
SunTrust analyst Jason Freuchtel raised his price target on Kraton Corporation to $55 from $45 to reflect industry valuation expansion and favorable earnings growth trends. Freuchtel sees the outlook for butadiene pricing as increasingly favorable in November and December as a result of falling natural rubber prices, decline in demand for Chinese butadiene, as well as seasonal trends. The analyst, who also anticipates some consolidation in Pine Materials industry next year, maintains a Buy rating on Kraton.
01/09/17
RHCO
01/09/17
NO CHANGE
RHCO
Kraton Performance named best idea at SunTrust
SunTrust analyst Jason Freuchtel identified Kraton as one of his best ideas of 2017. The analyst thinks that the company remains on track to generate $500M of free cash flow through 2018, representing about 20% of its enterprise value. He thinks that its 2017 earnings should be boosted by about $36M of savings and cost synergies, with similar items poised to meaningfully raise its 2018 earnings. Freuchtel thinks that the company's results could also be boosted by the recent FDA ban on powdered medical gloves or falling raw material prices. He keeps a $38 price target and a Buy rating on the shares.
09/28/17
LOOP
09/28/17
INITIATION
LOOP
Buy
Kraton Performance initiated with a Buy at Loop Capital
Loop Capital analyst Chris Kapsch initiated Kraton with a Buy rating and $65 price target.
09/29/17
LOOP
09/29/17
INITIATION
LOOP
Buy
Kraton Performance initiated at Loop Capital
As noted earlier, Loop Ca;ital started coverage of Kraton with a $65 price target and a Buy rating. Analyst Chris Kapsch says that the stock is "underappreciated and substantially undervalued," and he believes that the company has "several paths to unlocking much greater inherent value." The analyst believes that the stock has the most potential gains among the specialty chemicals names he covers.
PPG PPG
$117.34

1.49 (1.29%)

10/20/17
FBCO
10/20/17
NO CHANGE
Target $119
FBCO
Outperform
PPG 'story needs M&A' and deals are likely, says Credit Suisse
Credit Suisse analyst Christopher Parkinson said that despite PPG (PPG) "talking down" the potential for a renewed bid for Akzo Nobel (AKZOY), he still sees this as a distinct possibility, but he believes management would wait until the specialty chemicals spin is completed. Other "materially sized" potential targets include Germany's Beckers, Norway's Jotun and Japan's Kansai, said Parkinson, who contends that the PPG "story needs M&A." The analyst, who adjusted his 2018 and 2019 forecasts and raised his price target on PPG to $119 from $113, keeps an Outperform rating on the shares.
11/28/17
WELS
11/28/17
NO CHANGE
Target $120
WELS
Market Perform
PPG price target raised to $120 from $110 at Wells Fargo
Wells Fargo analyst Frank Mitsch raised his price target for PPG to $120 from $110 on valuation. The analyst reiterates a Market Perform rating on the shares.
07/24/17
07/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying the market seems to be pricing in an inflection in Goldman's trading revenue despite the recent weakness, suggesting a recovery is needed to justify 2018 consensus estimates. 2. Constellation Brands (STZ) downgraded to Neutral from Conviction Buy at Goldman Sachs. 3. Boston Beer (SAM) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying she sees further downside risk from weaker volumes and believes 2018 will be another year of volume decline and limited margin offset. 4. athenahealth (ATHN) downgraded to Underweight from Equal-Weight at First Analysis with analyst Frank Sparacino saying the valuation at current share levels is ahead of the underlying fundamentals in the short term. 5. PPG (PPG) was downgraded to Hold from Buy at SunTrust and to Neutral from Buy at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/17
JPMS
07/24/17
INITIATION
Target $365
JPMS
Neutral
Sherwin-Williams reinstated with a Neutral at JPMorgan
JPMorgan analyst Jeffrey Zekauskas reinstated coverage of Sherwin-Williams (SHW) with a Neutral rating and $365 price target. The anlayst prefers PPG (PPG) for its valuation.
TROX Tronox
$25.98

-1.44 (-5.25%)

10/24/17
JPMS
10/24/17
INITIATION
Target $30
JPMS
Overweight
Tronox initiated with an Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas started Tronox with an Overweight rating and $30 price target. The analyst expects the company to become a large, low-cost titanium dioxide producer with "excellent" free cash flow characteristics. He thinks Tronox has room to increase its EBITDA meaningfully over the coming three years.
07/05/17
07/05/17
NO CHANGE

Tronox increases soda ash prices
Tronox Limited announced that, effective immediately or as contract terms permit, Tronox Alkali will increase soda ash prices by $6.00 per short ton for all grades of soda ash. The increase applies to both bulk and packaged products. Tronox Alkali freight policy remains unchanged with all agreements on a freight collect basis. On customer request, Tronox will prepay all transportation charges - inclusive of fuel surcharges - and add these charges to the invoice with a $1.00 per short ton service charge. Tronox Alkali's current energy surcharge program remains in effect.
10/23/17
VERT
10/23/17
INITIATION
Target $32
VERT
Buy
Tronox initiated with a Buy at Vertical Research
Vertical Research analyst Matthew DeYoe initiated Tronox with a Buy and $32 price target saying he expects the next three-to-five year period to marked by TiO2 inflation, steady incremental pricing initiatives, creeping capacity additions, and strong free cash flow. The analyst expects the Tronox's integrated business model will enable the capture of margin throughout the TiO2 chain.
10/24/17
10/24/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boston Scientific (BSX) initiated with a Buy at Canaccord. 2. PQ Group (PQG) was initiated with a Buy at Nomura Instinet, Jefferies, Deutsche Bank, and Citi, an Overweight at KeyBanc, and a Neutral at JPMorgan and Goldman Sachs. 3. Tronox (TROX) initiated with an Overweight at JPMorgan. 4. Equinix (EQIX) initiated with a Buy at Deutsche Bank. 5. BioTelemetry (BEAT) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NFLX

Netflix

$190.12

0.56 (0.30%)

, DIS

Disney

$111.27

0.7 (0.63%)

20:03
12/17/17
12/17
20:03
12/17/17
20:03
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

NFLX

Netflix

$190.12

0.56 (0.30%)

DIS

Disney

$111.27

0.7 (0.63%)

FOXA

21st Century Fox

$34.99

0.11 (0.32%)

FOX

21st Century Fox

MSGN

MSG Networks

$19.80

0.05 (0.25%)

AMCX

AMC Networks

$55.33

1.16 (2.14%)

VIAB

Viacom

$30.24

0.53 (1.78%)

VIA

Viacom

$34.40

0.25 (0.73%)

XOM

Exxon Mobil

$83.03

0.13 (0.16%)

ONCE

Spark Therapeutics

$46.37

1.16 (2.57%)

ALK

Alaska Air

$70.83

1.44 (2.08%)

ORCL

Oracle

$48.30

-1.89 (-3.77%)

HUM

Humana

$253.64

3.03 (1.21%)

KND

Kindred Healthcare

$8.60

0.45 (5.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jan

  • 08

    Feb

  • 08

    Feb

CME

CME Group

$151.07

0.65 (0.43%)

19:31
12/17/17
12/17
19:31
12/17/17
19:31
Periodicals
CME becomes second exchange to launch bitcoin futures, Reuters says »

CME Group became the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$19.04

0.38 (2.04%)

19:10
12/17/17
12/17
19:10
12/17/17
19:10
Hot Stocks
Spectrum Pharmaceuticals terminates Rajesh Shrotriya from CEO position »

Spectrum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SO

Southern Company

$51.31

-0.21 (-0.41%)

18:58
12/17/17
12/17
18:58
12/17/17
18:58
Hot Stocks
Georgia Power expects power to be restored by midnight tonight »

Georgia Power continues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$43.08

0.74 (1.75%)

, XOM

Exxon Mobil

$83.03

0.13 (0.16%)

18:29
12/17/17
12/17
18:29
12/17/17
18:29
Periodicals
BHP, Esso to separately market Gippsland Basin gas, Reuters says »

The Australian…

BHP

BHP Billiton

$43.08

0.74 (1.75%)

XOM

Exxon Mobil

$83.03

0.13 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

17:48
12/17/17
12/17
17:48
12/17/17
17:48
Hot Stocks
Bombardier wins contract to provide Melbourne high-capacity signaling system »

Bombardier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$90.25

0.6 (0.67%)

, CMCSA

Comcast

$39.71

0.59 (1.51%)

17:38
12/17/17
12/17
17:38
12/17/17
17:38
Hot Stocks
Box Office Battle: 'Star Wars: The Last Jedi'' opens to $220M in U.S. »

Disney (DIS) and…

TWX

Time Warner

$90.25

0.6 (0.67%)

CMCSA

Comcast

$39.71

0.59 (1.51%)

CMCSK

Comcast

SNE

Sony

$44.84

0.39 (0.88%)

FOX

21st Century Fox

FOXA

21st Century Fox

$34.99

0.11 (0.32%)

LGF.A

Lionsgate

$32.99

0.49 (1.51%)

DIS

Disney

$111.27

0.7 (0.63%)

VIAB

Viacom

$30.24

0.53 (1.78%)

VIA

Viacom

$34.40

0.25 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 08

    Feb

EQIX

Equinix

$457.85

-2.5 (-0.54%)

17:17
12/17/17
12/17
17:17
12/17/17
17:17
Hot Stocks
Equinix announces acquisition of Metronode »

Equinix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$51.41

-1.08 (-2.06%)

17:11
12/17/17
12/17
17:11
12/17/17
17:11
Periodicals
Metlife failed to pay some pensions, Reuters reports »

Metlife failed to pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

GM

General Motors

$40.95

0.14 (0.34%)

17:06
12/17/17
12/17
17:06
12/17/17
17:06
Periodicals
GM facing $1B reckoning in ignition-switch settlement, WSJ reports »

General Motors faces a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 16

    Jan

TCEHY

Tencent

$50.31

-0.231 (-0.46%)

, BABA

Alibaba

$173.55

1.8 (1.05%)

16:58
12/17/17
12/17
16:58
12/17/17
16:58
Periodicals
Tencent to buy stake in supermarket chain, Bloomberg reports »

Tencent (TCEHY) to buy a…

TCEHY

Tencent

$50.31

-0.231 (-0.46%)

BABA

Alibaba

$173.55

1.8 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,179.14

4.88 (0.42%)

16:50
12/17/17
12/17
16:50
12/17/17
16:50
Periodicals
Amazon in talks to acquire Sqrrl, Axios reports »

Amazon is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

HUM

Humana

$253.64

3.03 (1.21%)

, KND

Kindred Healthcare

$8.60

0.45 (5.52%)

16:48
12/17/17
12/17
16:48
12/17/17
16:48
Periodicals
Humana in talks to acquire Kindred Healthcare, Reuters reports »

Humana (HUM) is in…

HUM

Humana

$253.64

3.03 (1.21%)

KND

Kindred Healthcare

$8.60

0.45 (5.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.30

-1.89 (-3.77%)

16:39
12/17/17
12/17
16:39
12/17/17
16:39
Hot Stocks
Oracle buys Aconex for $1.2B »

Oracle announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$52.93

-4.38 (-7.64%)

16:35
12/17/17
12/17
16:35
12/17/17
16:35
Hot Stocks
CSX announces death of CEO E. Hunter Harrison »

CSX issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRX

Valeant

$19.71

0.03 (0.15%)

16:09
12/17/17
12/17
16:09
12/17/17
16:09
Hot Stocks
Valeant, subsidiary announce early tender results »

Valeant Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

  • 18

    Jun

KMF

Kayne Anderson Midstream/Energy Fund

$13.78

0.09 (0.66%)

16:01
12/17/17
12/17
16:01
12/17/17
16:01
Hot Stocks
Kayne Anderson Midstream/Energy Fund announces distribution of 30c per share »

Kayne Anderson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KYN

Kayne Anderson MLP

15:59
12/17/17
12/17
15:59
12/17/17
15:59
Hot Stocks
Kayne Anderson MLP announces distribution of 45c per share for Q4 »

Kayne Anderson MLP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KED

Kayne Anderson Energy

$16.68

-0.01 (-0.06%)

15:56
12/17/17
12/17
15:56
12/17/17
15:56
Hot Stocks
Kayne Anderson Energy announces distribution 40c per share for Q4 »

Kayne Anderson Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KYE

Kayne Anderson Energy

$10.19

-0.01 (-0.10%)

15:53
12/17/17
12/17
15:53
12/17/17
15:53
Hot Stocks
Kayne Anderson Energy announces distribution of 25c per share for Q4 »

Kayne Anderson Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$52.93

-4.38 (-7.64%)

15:18
12/16/17
12/16
15:18
12/16/17
15:18
Hot Stocks
CSX announces death of CEO E. Hunter Harrison »

CSX issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

CBOE Holdings

$126.37

0.31 (0.25%)

11:22
12/16/17
12/16
11:22
12/16/17
11:22
Periodicals
CBOE should not be treated as 'set and forget,' Barron's says »

Bitcoin futures have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$111.27

0.7 (0.63%)

, FOXA

21st Century Fox

$34.99

0.11 (0.32%)

11:17
12/16/17
12/16
11:17
12/16/17
11:17
Periodicals
Disney/Fox 'a murky web of deals within deals,' Barron's says »

Walt Disney's (DIS)…

DIS

Disney

$111.27

0.7 (0.63%)

FOXA

21st Century Fox

$34.99

0.11 (0.32%)

FOX

21st Century Fox

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$70.83

1.44 (2.08%)

10:53
12/16/17
12/16
10:53
12/16/17
10:53
Periodicals
Alaska air should bounce back in 2018, Barron's says »

While shares of Alaska…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$46.37

1.16 (2.57%)

10:42
12/16/17
12/16
10:42
12/16/17
10:42
Periodicals
Spark Therapeutics selloff may be overdone, Barron's says »

Spark Therapeutics shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.